art%3A10.1186%2Fcc5931.pdf (112.91 kB)
Download file

Recently published papers: Therapies failed, disputed, and beneficent

Download (112.91 kB)
journal contribution
posted on 14.04.2016, 09:30 by Gareth Williams
A recent meta-analysis puts another nail in the coffin of a therapy that held great promise for management of acute respiratory distress syndrome. Two papers further highlight the growing controversy surrounding the safety profile of drotrecogin alfa (activated) and increase the clamour for a new independent trial. Also covered are steroids and their role in preventing postoperative atrial fibrillation, and success in instituting hypothermia after cardiac arrest. Finally, which form of renal replacement therapy should we be using in the intensive care unit?

History

Citation

Critical Care 2007 11:143

Version

VoR (Version of Record)

Published in

Critical Care 2007 11:143

Publisher

BioMed Central, Critical Care Canada Forum (CCCF), International Symposium on Intensive Care and Emergency Medicine (ISICEM)

issn

1364-8535

eissn

1466-609X

Available date

14/04/2016

Publisher version

http://ccforum.biomedcentral.com/articles/10.1186/cc5931

Language

en

Usage metrics

Categories

Keywords

Licence

Exports